Found: 6
Select item for more details and to access through your institution.
Atazanavir Is a Competitive Inhibitor of SARS-CoV-2 M pro , Impairing Variants Replication In Vitro and In Vivo.
- Published in:
- Pharmaceuticals (14248247), 2022, v. 15, n. 1, p. 21, doi. 10.3390/ph15010021
- By:
- Publication type:
- Article
Pharmacokinetics of chloroquine and primaquine in healthy volunteers.
- Published in:
- Malaria Journal, 2022, v. 21, n. 1, p. 1, doi. 10.1186/s12936-021-04035-z
- By:
- Publication type:
- Article
Safety, Efficacy and Pharmacokinetics of Ritonavir 400mg/Saquinavir 400mg Twice Daily plus Rifampicin Combined Therapy in HIV Patients with Tuberculosis.
- Published in:
- Clinical Drug Investigation, 2006, v. 26, n. 8, p. 469, doi. 10.2165/00044011-200626080-00005
- By:
- Publication type:
- Article
Development and validation of LC–MS/MS methods for the simultaneous quantification of sofosbuvir and its major metabolite (GS‐331007) in blood plasma and cerebrospinal and seminal fluid: Application to a pilot clinical trial with a focus on Zika
- Published in:
- Biomedical Chromatography, 2023, v. 37, n. 5, p. 1, doi. 10.1002/bmc.5606
- By:
- Publication type:
- Article
Cynomolgus monkeys are successfully and persistently infected with hepatitis E virus genotype 3 (HEV-3) after long-term immunosuppressive therapy.
- Published in:
- PLoS ONE, 2017, v. 12, n. 3, p. 1, doi. 10.1371/journal.pone.0174070
- By:
- Publication type:
- Article
Pharmacokinetics/pharmacodynamics of chloroquine and artemisinin-based combination therapy with primaquine.
- Published in:
- Malaria Journal, 2019, v. 18, n. 1, p. N.PAG, doi. 10.1186/s12936-019-2950-4
- By:
- Publication type:
- Article